PHIOW
Phio Pharmaceuticals Corp
Halal Rating :
Last Price
$0.02
Last updated:
Market Cap
-
7D Change
0.0%
1 Year Change
0.0%
Company Overview
Industries
Exchange
Next Earnings Date
Phio Pharmaceuticals Corp is a biotechnology company developing novel therapeutic treatments using its proprietary INTASYL™ RNAi technology platform. The company focuses on immuno-oncology treatments, specifically developing therapies that enhance the immune system's ability to fight cancer. The company is currently in pre-clinical and early clinical development stages, with no commercial products yet available.
Use of Interest
| Reporting Date | Total Revenue | Total Operating Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|
Company Impact
Help us evaluate Phio Pharmaceuticals Corp's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.